OBJ
PUBLIC
STATUS
1-10
EMPLOYEES
OBJ
STOCK SYMBOL
1
INVESTMENTS
$0.01
SHARE PRICE
(As of Thursday Closing)
Description
OBJ Ltd is engaged in the research and development for Dermaportation and ETP transdermal drug delivery technologies. Geographically, it derives a majority of revenue from Singapore and also has a presence in Japan. It serves Pharmaceutical; Cosmetics and Skincare and Consumer Healthcare industries.
Primary Industry
Drug Delivery
Stock Exchange
ASX
Primary Office
- Perth
- Australia
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore OBJ’s full profile, request a free trial.
OBJ Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $18.7M | $0.01 | 1.18M | 1.81B |
OBJ Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2019
30-Jun-2019
|
FY 2018
30-Jun-2018
|
FY 2017
30-Jun-2017
|
|---|---|---|---|---|
| Enterprise Value | 18,162 | 15,870 | 33,590 | 61,535 |
| Revenue | 893 | |||
| EBITDA | (1,197) | (1,303) | (4,164) | |
| Net Income | (1,223) | (1,316) | (4,173) | |
| Total Assets | 2,197 | 3,531 | 4,769 | |
| Total Debt | 176 | 175 | 172 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
OBJ Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 0000000 | 07-Nov-2019 | 000000000000000000 | 0000 | Food Products |